NDC 39822-3030-02 - Pentamidine Isethionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 39822-3030
- Requested NDC
- 39822-3030-02
- Package NDCs from labels
- 39822-3030-1, 39822-3030-2, 39822-3030-02
- Manufacturer
- XGen Pharmaceuticals DJB, Inc.
- Effective date
- 2026-10-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pentamidine Isethionate for Inhalation, 300mg/vial | XGen Pharmaceuticals DJB, Inc. | 2026-10-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 39822-3030-1 | Pentamidine Isethionate | 6 mL in 1 VIAL, SINGLE-DOSE | INHALANT | 6 | 6 | |
| 39822-3030-2 | Pentamidine Isethionate | 1 in 1 CARTON | INHALANT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 39822-3030 | PENTAMIDINE ISETHIONATE INHALANT [XGEN PHARMACEUTICALS DJB, INC.] | 6 | Current NDC, 2 package rows | 20240320_490a231d-bb24-403d-9733-1a562ecd5917.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 39822-3030-1 | EA - Each | 39822-3030 | 66f4b4e2-7c76-4e82-851e-b887e19e2346 | 1 | 2023-07-06 |
| 39822-3030-2 | EA - Each | 39822-3030 | 26e07bd3-dddf-43aa-aae5-f51bc1ff2249 | 1 | 2023-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | PAI Holdings, LLC dba PAI Pharma | 4c01d8e9-a25b-4046-8924-53bd9acd560d | 2026-06-12 | Warnings, Adverse reactions | 861597 V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | PAI Holdings, LLC dba PAI Pharma | d46aea4f-8f3f-4ce0-93d6-94e147f5a31a | 2026-05-07 | Warnings, Adverse reactions | V2P3K60DA2 |
| pentamidine isethionate | PENTAMIDINE ISETHIONATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 5c14fbf2-e21f-44b3-b35c-06919d40d7e0 | 2025-10-31 | Warnings, Adverse reactions | V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | Seton Pharmaceuticals | c484f16e-9d97-4416-84a4-8ad8deaf5e19 | 2025-04-08 | Warnings, Adverse reactions | 861597 V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | Seton Pharmaceuticals | cb8e8155-5505-44d5-9dee-525e2e45b95d | 2025-04-02 | Warnings, Adverse reactions | V2P3K60DA2 |
| NebuPent | PENTAMIDINE ISETHIONATE | Fresenius Kabi USA, LLC | e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb | 2024-10-15 | Warnings, Adverse reactions | 861597 V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | XGen Pharmaceuticals DJB, Inc. | 490a231d-bb24-403d-9733-1a562ecd5917 | 2024-03-18 | Warnings, Adverse reactions | ANDA206983 39822-3030-1 39822-3030-2 39822-3030 39822303002 861597 13f0833c-208d-be41-e063-6294a90a627b 490a231d-bb24-403d-9733-1a562ecd5917 V2P3K60DA2 |
| PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | XGen Pharmaceuticals DJB, Inc. | 860c799c-5199-4f0c-b21b-9910273474d9 | 2024-01-25 | Warnings, Adverse reactions | V2P3K60DA2 |
| Pentam 300 | PENTAMIDINE ISETHIONATE | Fresenius Kabi USA, LLC | cc2b635e-4840-4dc3-a177-5484371680e8 | 2022-09-13 | Warnings, Adverse reactions | V2P3K60DA2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.